|
Re: Insider Selling
|
4
|
Resverlogix Corp.
|
Jul 14, 2019 10:30AM
|
|
Re: Likelihood of BETonMACE getting FDA/US involvement
|
4
|
Resverlogix Corp.
|
Jun 02, 2017 10:37AM
|
|
Re: Exposure in Motley Fool....
|
4
|
Resverlogix Corp.
|
Oct 09, 2019 01:51PM
|
|
March Madness?
|
4
|
Resverlogix Corp.
|
Mar 06, 2018 08:53AM
|
|
Re: Bromodomain-2 Selective BET inhibitors
|
4
|
Resverlogix Corp.
|
Apr 22, 2018 07:47PM
|
|
Zenith BIO International presentation June 4th 2:30 to 2:45 EST
|
4
|
Zenith Epigenetics
|
Jun 02, 2018 03:53PM
|
|
Re: BET inhibitors and Pulmonary Hypertension
|
4
|
Resverlogix Corp.
|
Aug 01, 2018 02:33PM
|
|
Re: A New Frontier in CV Risk Reduction for Patients With Type 2 Diabetes
|
4
|
Resverlogix Corp.
|
Dec 18, 2018 02:26PM
|
|
biOasis Announces the Issuance of an Additional US Patent
|
4
|
BIOASIS TECHNOLOGIES INC
|
Jul 11, 2016 07:27AM
|
|
Re: NFK meeting
|
4
|
Resverlogix Corp.
|
Feb 20, 2020 11:38AM
|
|
Re: The last DSMB update of Feb 26th....
|
4
|
Resverlogix Corp.
|
Jun 25, 2018 11:07AM
|
|
Re: Zenith and Pfizer collaboration news
|
4
|
Resverlogix Corp.
|
Nov 20, 2018 10:00AM
|
|
Re: What kind of info should we expect from the SSA?
|
4
|
Resverlogix Corp.
|
Apr 22, 2018 08:17PM
|
|
Re: A few comments
|
4
|
Resverlogix Corp.
|
Jan 12, 2017 03:54PM
|
|
Resverlogix needs to host another R&D Day for Investors and Analysts
|
4
|
Resverlogix Corp.
|
Jul 03, 2018 10:24AM
|
|
Re: 8 year high
|
4
|
Resverlogix Corp.
|
Sep 05, 2018 02:48PM
|
|
Re: ACC 2019?
|
4
|
Resverlogix Corp.
|
Dec 07, 2018 10:35AM
|
|
Re: Resverlogix Announces US$30 Million Loan Commitment Letter .
|
4
|
Resverlogix Corp.
|
Apr 11, 2018 08:33AM
|
|
Re: Resverlogix Announces Conversion of US$12 Million Debenture Strengthening Balance Sheet
|
4
|
Resverlogix Corp.
|
Oct 14, 2020 05:18PM
|
|
Re: AACR April 24-29, 2020 for some Zenith Clinical Trial Results?
|
4
|
Zenith Epigenetics
|
Mar 24, 2020 12:31PM
|
